港股上市公司基石药业-B（02616.HK）今日盘中大跌5.2%，引发市场关注。该公司股价的大幅下跌与其最新公布的配股计划密切相关。
据悉，基石药业计划配售合共8000万股配售股份，配售价为每股2.933港元。公司预计此次配股的所得款项净额约为2.32亿港元，其中90%将用于集团"管线2.0"中的资产。这一举措虽然有助于公司筹集资金推进业务发展，但同时也可能导致股份稀释，这通常会对股价产生短期负面影响。
市场分析人士指出，投资者对配股消息的反应导致了基石药业股价的急剧下跌。然而，长期来看，公司如何有效利用这笔资金来推进"管线2.0"项目的发展，将是决定其未来股价走势的关键因素。投资者需密切关注公司后续的业务进展及资金使用情况。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.